CD34 and mesenchymal cell neoplasm: It was previously proposed that CD34 loss was associated with malignant progression in mesenchymal tumors such as dermatofibrosarcoma protuberans15, 16, solitary fibrous tumors17, 18, and phyllodes tumors19–21.